NF-κB-mediated miR-30b regulation in cardiomyocytes cell death by targeting Bcl-2

Molecular and Cellular Biochemistry

Volumn 387, Issue 1-2, 2014, Pages 135-141

  Wei, Chuanyu ^a,b,c   Li, Li ^a,b,c   Gupta, Sudhiranjan ^a,b,c  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bcl 2; Cardiac apoptosis; miR 30b; NF B

Indexed keywords

3' UNTRANSLATED REGIONS; ANGIOTENSIN II; ANIMALS; APOPTOSIS; BASE SEQUENCE; HEK293 CELLS; HUMANS; MICRORNAS; MYOCYTES, CARDIAC; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84893845668     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1878-1     Document Type: Article

References (43)

1. Colucci WS (1996) Apoptosis in the heart. N Engl J Med 335:1224-1226 (Pubitemid 26339779)
2. MacLellan WR, Schneider MD (1997) Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 81:137-144 (Pubitemid 27342480)
3. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P (1997) Apoptosis in the failing human heart. N Engl J Med 336:1131-1141 (Pubitemid 27374695)
4. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivetti G, Anversa P (1996) Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226:316-327 (Pubitemid 26260556)
5. Cigola E, Kajstura J, Li B, Meggs LG, Anversa P (1997) Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res 231:363-371 (Pubitemid 27187989)
6. Hasegawa K, Iwai-Kanai E, Sasayama S (2001) Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure. J Cell Physiol 186:11-18
7. Rouet-Benzineb P, Gontero B, Dreyfus P, Lafuma C (2000) Angiotensin II induces nuclear factor- kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J Mol Cell Cardiol 32:1767-1778
8. Lee KH, Jang Y, Chung JH (2010) Heat shock protein 90 regulates IkappaB kinase complex and NF-kappaB activation in angiotensin II-induced cardiac cell hypertrophy. Exp Mol Med 42:703-711
9. Omura T, Yoshiyama M, Kim S, Matsumoto R, Nakamura Y, Izumi Y, Ichijo H, Sudo T, Akioka K, Iwao H, Takeuchi K, Yoshikawa J (2004) Involvement of apoptosis signal-regulating kinase-1 on angiotensin II-induced monocyte chemoattractant protein-1 expression. Arterioscler Thromb Vasc Biol 24:270-275 (Pubitemid 38197577)
10. Maier HJ, Schips TG, Wietelmann A, Kruger M, Brunner C, Sauter M, Klingel K, Bottger T, Braun T, Wirth T (2012) Cardiomyocyte-specific IkappaB kinase (IKK)/NF-kappaB activation induces reversible inflammatory cardiomyopathy and heart failure. Proc Natl Acad Sci USA 109:11794-11799
11. Zelarayan L, Renger A, Noack C, Zafiriou MP, Gehrke C, van der Nagel R, Dietz R, de Windt L, Bergmann MW (2009) NF-kappaB activation is required for adaptive cardiac hypertrophy. Cardiovasc Res 84:416-424
12. Timmers L, van Keulen JK, Hoefer IE, Meijs MF, van Middelaar B, den Ouden K, van Echteld CJ, Pasterkamp G, de Kleijn DP (2009) Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction. Circ Res 104:699-706
13. Van der Heiden K, Cuhlmann S, le Luong A, Zakkar M, Evans PC (2010) Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci (Lond) 118:593-605
14. Gupta S, Purcell NH, Lin A, Sen S (2002) Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. J Cell Biol 159:1019-1028 (Pubitemid 36055756)
15. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, Mahajan A, Wang Q, Sen S (2008) Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol 375:637-649
16. Young D, Popovic ZB, Jones WK, Gupta S (2008) Blockade of NF-kappaB using IkappaB alpha dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice. J Mol Biol 381:559-568
17. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297 (Pubitemid 38167318)
18. Cullen BR (2004) Transcription and processing of human microRNA precursors. Mol Cell 16:861-865 (Pubitemid 40018397)
19. Latronico MV, Catalucci D, Condorelli G (2007) Emerging role of microRNAs in cardiovascular biology. Circ Res 101:1225-1236 (Pubitemid 350294639)
20. van Rooij E, Olson EN (2007) MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117:2369-2376 (Pubitemid 47494334)
21. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Hoydal M, Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613-618 (Pubitemid 46828487)
22. Topkara VK, Mann DL (2011) Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther 25:171-182
23. Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgiou AG, Fraser NW (2006) Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442:82-85 (Pubitemid 44064213)
24. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40:43-50
25. Ichikawa T, Sato F, Terasawa K, Tsuchiya S, Toi M, Tsujimoto G, Shimizu K (2012) Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells. PLoS One 7:e31422
26. He J, Jiang S, Li FL, Zhao XJ, Chu EF, Sun MN, Chen MZ, Li H (2013) MicroRNA-30b-5p is involved in the regulation of cardiac hypertrophy by targeting CaMKIIdelta. J Investig Med 61:604-612
27. Bridge G, Monteiro R, Henderson S, Emuss V, Lagos D, Georgopoulou D, Patient R, Boshoff C (2012) The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood 120:5063-5072
28. Wei C, Kumar S, Kim IK, Gupta S (2012) Thymosin beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes. PLoS One 7:e42586
29. Wei C, Kim IK, Kumar S, Jayasinghe S, Hong N, Castoldi G, Catalucci D, Jones WK, Gupta S (2013) NF-kappaB mediated miR-26a regulation in cardiac fibrosis. J Cell Physiol 228:1433-1442
30. Masri C, Chandrashekhar Y (2008) Apoptosis: a potentially reversible, meta-stable state of the heart. Heart Fail Rev 13:175-179
31. Schroder D, Heger J, Piper HM, Euler G (2006) Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat. J Mol Med (Berl) 84:975-983 (Pubitemid 44655875)
32. Huang ZP, Neppl RL, Wang DZ (2010) MicroRNAs in cardiac remodeling and disease. J Cardiovasc Transl Res 3:212-218
33. Li P (2010) MicroRNAs in cardiac apoptosis. J Cardiovasc Transl Res 3:219-224
34. Oikonomou E, Siasos G, Tousoulis D, Kokkou E, Genimata V, Zisimos K, Latsios G, Stefanadis C (2013) Diagnostic and therapeutic potentials of microRNAs in heart failure. Curr Top Med Chem 13:1548-1558
35. Zhou R, Hu G, Gong AY, Chen XM (2010) Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells. Nucleic Acids Res 38:3222-3232
36. Olarerin-George AO, Anton L, Hwang YC, Elovitz MA, Hogenesch JB (2013) A functional genomics screen for microRNA regulators of NF-kappaB signaling. BMC Biol 11:19
37. Ma X, Becker Buscaglia LE, Barker JR, Li Y (2011) MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 3:159-166
38. Jiang L, Lin C, Song L, Wu J, Chen B, Ying Z, Fang L, Yan X, He M, Li J, Li M (2012) MicroRNA-30e promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB/IkappaBalpha negative feedback loop. J Clin Invest 122:33-47
39. Weigel AL, Handa JT, Hjelmeland LM (2002) Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med 33:1419-1432 (Pubitemid 35284925)
40. Wang G, Liem DA, Vondriska TM, Honda HM, Korge P, Pantaleon DM, Qiao X, Wang Y, Weiss JN, Ping P (2005) Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 288:H1290-H1295 (Pubitemid 40270036)
41. Vogler M (2012) BCL2A1: the underdog in the BCL2 family. Cell Death Differ 19:67-74
42. Catz SD, Johnson JL (2001) Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20:7342-7351 (Pubitemid 33078205)
43. Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, Chalbos D, Sonenshein GE (2007) Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol 9:470-478 (Pubitemid 46511081)